0.17
0.17 (0%)
As of Nov 04, 2024
Novo Integrated Sciences, Inc. [NVOS]
Source:
Company Overview
Novo Integrated Sciences, Inc owns Canadian and U.S. subsidiaries which provide, or intend to provide, essential and differentiated solutions to the delivery of multidisciplinary primary care and related wellness products through the integration of medical technology, interconnectivity, advanced therapeutics, diagnostic solutions, unique personalized product offerings, and rehabilitative science.
| Country | United States |
| Headquarters | bellevue, washington |
| Phone Number | (206) 617-9797 |
| Industry | manufacturing |
| CEO | Robert Mattacchione |
| Website | www.novointegrated.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $13.3 |
| Operating Profit | $-10.1 |
| Net Income | $-16.1 |
| Net Cash | $0.4 |
Profit Ratios
| Gross Margin | $5.7 |
| Operating Margin | -75.8 |
| Profit as % of Revenues | -35.6% |
| Profit as % of Assets | -47.6% |
| Profit as % of Stockholder Equity | -110.4% |
Management Effectiveness
| Return on Equity | -110.4% |
| Return on Assets | -50.2% |
| Turnover Ratio | 39.3% |
| EBITA | $-10.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $32.1 |
| Total Liabilities | $17.5 |
| Operating Cash Flow | $-5.1 |
| Investing Cash Flow | $-0 |
| Financing Cash Flow | $5 |
